Success Story: Connecting Healthcare Data & Sales
Visible Genomics
“Working in a lab setting brings up a unique set of challenges, including how we handle sensitive medical data. Slingr not only made our development process faster and cheaper but provided end-to-end HIPAA compliance that was crucial for building applications that met our rigorous privacy standards.”
Scott Rediger, CEO
Our Client
Visible Genomics has applied decades of experience to develop genetic age-related macular degeneration (AMD) diagnosis testing capabilities. Historically, people who suffer from this severe ocular disease are frequently diagnosed after severe symptoms appear. Because they did not understand their risk profile, they could not take proactive measures to slow or prevent its progression (i.e., loss of vision). Many can’t afford genetic testing, and most insurance will not cover it.
The Visible Genomics solution offers a comprehensive risk assessment to help provide advanced awareness of disease risk. An early alert enables the patient and healthcare professional to make informed clinical and lifestyle decisions to help slow or prevent disease. By taking advantage of modern software options and leveraging Slingr ́s low-code solutions, Visible Genomics provides greater access to testing for more patients through affordable, accessible, and understandable risk Testing.
Our Work
As a HIPAA-compliant provider, Slingr has internalized development procedures to deliver applications that meet all major healthcare regulatory standards and support changing healthcare dynamics. For example, Visible Genomics rapidly re-tooled its platform to adapt to disruptive COVID circumstances. In addition to supporting testing at physician practices, Visible genomics offered an option to send test kits to patients' homes. The enhanced platform is now a key component of Visible Genomics’ everyday business operations. This project's most challenging aspect was accessing the algorithm calculating a patient’s probability of suffering from AMD. By developing an endpoint to contain the algorithm, raw genetic data seamlessly flows from the laboratory information management through the interpretation process in the endpoint to create a report in the Visible Genomics application accessible to patients, physicians, and genetic Counselors.
Our Impact
Re-tooling to adapt to COVID restrictions
Seamless consolidation of uploaded raw data
Integration to the algorithm to calculate probabilities of AMD based on
tests results
Online sales module enabled